NMC
NKTR icon

NEA Management Company’s Nektar Therapeutics NKTR Stock Holding History

NEA Management Company’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-121,707
Closed -$22M – 36
2014
Q3 		$22M Hold
121,707
– – 1.12% 20
2014
Q2 		$23.4M Hold
121,707
– – 1.1% 17
2014
Q1 		$22.1M Hold
121,707
– – 1.09% 16
2013
Q4 		$20.7M Hold
121,707
– – 1% 16
2013
Q3 		$19.1M Hold
121,707
– – 0.76% 18
2013
Q2 		$21.1M Buy
+121,707
New +$18.7M 0.94% 16

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

NEA Management Company's NKTR Position: Q4 2014 in Review

NEA Management Company sold out of Nektar Therapeutics (NKTR) in Q4 2014, closing a stake of 121,707 shares — an estimated $22M sold.

NEA Management Company first reported a position in NKTR in Q2 2013 and held it in 6 quarters. The position peaked at $23.4M in Q2 2014. 163 funds tracked by Wall St. Rank hold NKTR as of Q4 2014.

  • NEA Management Company reported no remaining Nektar Therapeutics position as of Q4 2014 after selling out during the quarter.
  • NEA Management Company sold 121,707 Nektar Therapeutics shares in Q4 2014, an estimated $22M.
  • NEA Management Company first reported a position in Nektar Therapeutics in Q2 2013 and held it in 6 quarters.
  • NEA Management Company's Nektar Therapeutics position peaked at $23.4M in Q2 2014.
  • 163 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2014.

Based on NEA Management Company's 13F filing for Q4 2014, filed 26 Jan 2015.